Ignite Creation Date:
2024-05-05 @ 4:47 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00312039
Status:
COMPLETED
Last Update Posted:
2023-08-25
First Post:
2006-04-05
Brief Title:
Study of Once Daily Elvucitabine Versus Lamivudine in Participants With a Documented M184V Mutation
Sponsor:
Alexion Pharmaceuticals Inc
Organization:
Alexion Pharmaceuticals Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-03-31
Start Date Type:
ACTUAL
Primary Completion Date:
2007-10-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-10-31
Completion Date Type:
ACTUAL
First Submit Date:
2006-04-05
First Submit QC Date:
April 6 2006
Study First Post Date:
2006-04-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-22
Last Update Post Date:
2023-08-25
Last Update Post Date Type:
ACTUAL